Archiv der Kategorie ‘Teva‘

Jim Cramers 6 Stocks in 60 Seconds: BP SBUX CL HLF TEVA LINE

Tuesday, den 29. October 2013

Undervalued Teva Must Enter New Markets

Wednesday, den 12. June 2013

Teva Pharmaceutical Industries Hits Estimates, But GAAP Results Lag Last Years

Sunday, den 5. May 2013

Teva Pharmaceuticals erleidet Gewinnrueckgang

Thursday, den 2. May 2013

Ratiopharm Mutter Teva Pharmaceuticals mit Gewinnrueckgang

Thursday, den 2. May 2013

Lonza stellt Biosimilar Geschaeft mit Teva auf den Pruefstand

Friday, den 5. April 2013

Is Teva Pharmaceuticals Stock Still Worth Owning?

Tuesday, den 2. April 2013

Teva Files 2012 Annual Report on Form 20 F

Saturday, den 9. March 2013

Teva Calls 5.550% Senior Notes Due 2016 for Redemption

Saturday, den 2. March 2013

Intevac Announces LIVAR Digital Camera Production Orders

Saturday, den 9. February 2013

Teva Pharmaceutical Industries neutral – New Analyst Rating from UBS AG

Tuesday, den 4. December 2012

Teva Pharmaceutical Industries neutral – New Analyst Rating from UBS AG

Monday, den 3. December 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Friday, den 31. August 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Thursday, den 30. August 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Monday, den 6. August 2012

Teva Pharmaceutical Industries hold – New Analyst Rating from Jefferies & Company Inc.

Tuesday, den 26. June 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Monday, den 25. June 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Monday, den 28. May 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Friday, den 11. May 2012

Teva Pharmaceutical Industries hold – New Analyst Rating from Needham & Company, LLC

Thursday, den 10. May 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Thursday, den 10. May 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Tuesday, den 24. April 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Monday, den 23. April 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Wednesday, den 7. March 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Tuesday, den 6. March 2012

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Friday, den 2. December 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Thursday, den 1. December 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Friday, den 4. November 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from UBS AG

Thursday, den 3. November 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from Societe Generale Group S.A.

Wednesday, den 2. November 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from Societe Generale Group S.A.

Tuesday, den 1. November 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from Citigroup Corp.

Thursday, den 6. October 2011

Teva Pharmaceutical Industries buy – New Analyst Rating from Citigroup Corp.

Wednesday, den 31. August 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from UBS AG

Wednesday, den 3. August 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from Societe Generale Group S.A.

Tuesday, den 26. July 2011

Teva Pharmaceuticals Industries kaufen – New Analyst Rating from Die Actien-Boerse

Monday, den 23. May 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from Citigroup Corp.

Wednesday, den 18. May 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from Citigroup Corp.

Tuesday, den 17. May 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from UBS AG

Friday, den 13. May 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from UBS AG

Tuesday, den 3. May 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from UBS AG

Tuesday, den 26. April 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from Societe Generale Group S.A.

Monday, den 28. March 2011

Teva Pharmaceuticals Industries neutral – New Analyst Rating from Credit Suisse Group

Monday, den 28. March 2011

P&G und Teva kooperieren bei rezeptfreien Medikamenten

Thursday, den 24. March 2011

Teva Pharmaceuticals Industries buy – New Analyst Rating from UBS AG

Wednesday, den 9. February 2011